May 17, 2012

More than 80% of health plans would require a drug manufacturer to demonstrate a clear clinical benefit compared with current branded and generic treatments in order for its drug to be placed in the plan's formulary, according to a new survey.

May 17, 2012

The Food and Drug Administration has approved generic versions of one of the country's top-selling drugs made by eight different companies, the agency said Thursday.

May 17, 2012

Sagent Pharmaceuticals has launched a generic version of a chemotherapy drug, the company said Thursday.

May 17, 2012

Wolters Kluwer Health has introduced what it called the first mobile application for the Nursing Drug Handbook, the company said Thursday.

May 16, 2012

Amneal Pharmaceuticals is adding blackberry flavoring to a generic diabetes drug following feedback from customers, the company said Wednesday.

May 16, 2012

Walmart and Sam's Club will be among the first retailers to offer a generic version of an antiplatelet drug.

May 16, 2012

Medication nonadherence costs the U.S. healthcare system about $290 billion per year, according to New England Healthcare Institute. That big and scary number — the kind whose sheer enormity can make one’s eyes glaze over — is now even bigger.


May 16, 2012

Watson has announced its intention to acquire Actavis, the company said. Following news reports that the U.S.-based generic drug maker would acquire Switzerland-based Actavis, Watson announced that it would buy the latter for $5.6 billion.

May 15, 2012

Net revenues for Teva rose more than 24% for the first quarter ended March 31, thanks to new drug launches and the company's acquisition of drug maker Cephalon.

May 15, 2012

First-quarter consolidated sales for generic drug maker Ranbaxy Labs totaled $736 million, the company reported last week.

May 15, 2012

Legislation proposed in the House of Representatives would speed up Food and Drug Administration approval of knock-off versions of vaccines and other biologics while requiring the agency to conduct more inspections of drug factories overseas, according to published reports.

May 15, 2012

Pfizer apparently is relenting on its attempt to drive sales of its top cholesterol drug as several new generic versions look set to enter the market, according to published reports.

May 15, 2012

Walgreens on Tuesday infused greater value into its Prescription Savings Club program, which now offers discounts on more than 8,000 brand-name and generic prescriptions, thanks to the inclusion of more than 700 "value-priced" generics, which retail as low as $12 for a 90-day supply.

May 14, 2012

Giant Food Stores collected nearly 3 tons of unused medications during a nationwide medication take-back day last month, the chain said.

May 11, 2012

Biotech drug maker Amgen has joined the list of companies offering testimony at a Food and Drug Administration hearing on biosimilars Friday.

May 10, 2012

Mylan has increased its 2012 earnings per share guidance range, the generic drug maker said.

May 10, 2012

Generic drug maker Watson Pharmaceuticals has formed a special office to handle its pending acquisition of Actavis, the company said.

May 10, 2012

Generic drug maker Watson Pharmaceuticals is hoping to be the first to market a generic version of a drug used to treat ulcerative colitis, the company said.

May 9, 2012

Kerr Drug announced the launch of its Healthy Pet program, offering a full range of pet medications that customers can order on the chain's website and have delivered to their homes, the regional retail pharmacy chain said Wednesday.

May 9, 2012

The Food and Drug Administration may be close to approving a drug for preventing HIV infection, according to published reports.

May 9, 2012

The Food and Drug Administration should apply consistent regulatory standards across all biologics, Sandoz plans to state Friday in testimony at an FDA public hearing on draft guidances related to the development of biosimilars.

May 8, 2012

An organization that promotes efforts to stop prescription drug abuse announced Tuesday the release of a mobile app that directs users to places where they can safely get rid of unwanted and unused medications.

May 8, 2012

A generic version of a schizophrenia drug made by Otsuka Holdings and Bristol-Myers Squibb can't be launched until April 2015, according to published reports.

May 8, 2012

University of British Columbia researchers may have found a way to develop universal flu vaccines and eliminate the need for seasonal flu vaccinations, university officials announced Tuesday.